Author Index
Search or browse for an author across our entire electronic archive
Search results for: K
Results 101 - 110 of 1817 shown below
Kakizaki, M
M Kakizaki, K Inoue, S Kuriyama, T Sone, K Matsuda-Ohmori, N Nakaya, S Fukudo and I Tsuji
Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study
advance online publication, 2008-06-10 00:00:00.000;
doi:10.1038/sj.bjc.6604425
Abstract | Full article | PDF
-
Q Li, M Kakizaki, S Kuriyama, T Sone, H Yan, N Nakaya, K Mastuda-Ohmori and I Tsuji
Green tea consumption and lung cancer risk: the Ohsaki study
advance online publication, 2008-09-02 00:00:00.000;
doi:10.1038/sj.bjc.6604645
Abstract | Full article | PDF
-
M Kakizaki, S Kuriyama, T Sone, K Ohmori-Matsuda, A Hozawa, N Nakaya, S Fukudo and I Tsuji
Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study
advance online publication, 2008-09-23 00:00:00.000;
doi:10.1038/sj.bjc.6604684
Abstract | Full article | PDF
-
Y Sugawara, S Kuriyama, M Kakizaki, M Nagai, K Ohmori-Matsuda, T Sone, A Hozawa, Y Nishino and I Tsuji
Fish consumption and the risk of colorectal cancer: the Ohsaki Cohort Study
advance online publication, 2009-07-28 00:00:00.000;
doi:10.1038/sj.bjc.6605217
Abstract | Full article | PDF
Kakizoe, T
T Hamaguchi, Y Matsumura, M Suzuki, K Shimizu, R Goda, I Nakamura, I Nakatomi, M Yokoyama, K Kataoka and T Kakizoe
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
advance online publication, 2005-03-22 00:00:00.000;
doi:10.1038/sj.bjc.6602479
Abstract | Full article | PDF
-
H Uchino, Y Matsumura, T Negishi, F Koizumi, T Hayashi, T Honda, N Nishiyama, K Kataoka, S Naito and T Kakizoe
Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
advance online publication, 2005-09-13 00:00:00.000;
doi:10.1038/sj.bjc.6602772
Abstract | Full article | PDF
Kakkar, A J
P H Jones, K Christodoulos, N Dobbs, P Thavasu, F Balkwill, A D Blann, G J Caine, S Kumar, A J Kakkar, N Gompertz, D C Talbot, T S Ganesan and A L Harris
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer
advance online publication, 2004-05-25 00:00:00.000;
doi:10.1038/sj.bjc.6601897
Abstract | Full article | PDF
-
A O'Donnell, A Padhani, C Hayes, A J Kakkar, M Leach, J M Trigo, M Scurr, F Raynaud, S Phillips, W Aherne, A Hardcastle, P Workman, A Hannah and I Judson
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points
doi:10.1038/sj.bjc.6602797
Abstract | Full article | PDF
Kaklamanis, L
K Smith, T D Bui, R Poulsom, L Kaklamanis, G Williams and A L Harris
Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer
doi:10.1038/sj.bjc.6690721
Kakolyris, S
J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, A Athanasiadis, S Kakolyris, S Tsousis, Ch Kouroussis, L Vamvakas, A Kalykaki, G Samonis, D Mavroudis and V Georgoulias
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic
advance online publication, 2006-02-28 00:00:00.000;
doi:10.1038/sj.bjc.6603011
Abstract | Full article | PDF
-
S Kakolyris, S B Fox, M Koukourakis, A Giatromanolaki, N Brown, R D Leek, M Taylor, I M Leigh, K C Gatter and A L Harris
Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
doi:10.1054/bjoc.1999.1010
-
K Kalbakis, Ch Kouroussis, S Kakolyris, D Mavroudis, J Souglakos, S Agelaki, L Vamvakas, M Christodoulakis, K Stylianou and V Georgoulias
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracyclin
doi:10.1054/bjoc.2001.2001
Kaku, T
K Sonoda, S Miyamoto, T Hirakawa, T Kaku, M Nakashima, T Watanabe, K Akazawa, T Fujita and H Nakano
Association between RCAS1 expression and clinical outcome in uterine endometrial cancer
doi:10.1038/sj.bjc.6601126
Abstract | Full article | PDF
Kakudo, K
Y Ito, H Yoshida, K Nakano, K Kobayashi, T Yokozawa, K Hirai, F Matsuzuka, N Matsuura, K Kakudo, K Kuma and A Miyauchi
Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid
doi:10.1038/sj.bjc.6600172
Abstract | Full article | PDF
-
Y Ito, H Yoshida, K Nakano, K Kobayashi, T Yokozawa, K Hirai, F Matsuzuka, N Matsuura, K Kakudo, K Kuma and A Miyauchi
Expression of cdc25A and cdc25B proteins in thyroid neoplasms
doi:10.1038/sj.bjc.6600364
Abstract | Full article | PDF
-
Y Ito, E Miyoshi, N Sasaki, K Kakudo, H Yoshida, C Tomoda, T Uruno, Y Takamura, A Miya, K Kobayashi, F Matsuzuka, N Matsuura, K Kuma and A Miyauchi
Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma
doi:10.1038/sj.bjc.6601540
Abstract | Full article | PDF
Kakudo, Y
T Yoshioka, S Kato, M Gamoh, N Chiba, T Suzuki, N Sakayori, S Kato, H Shibata, H Shimodaira, K Otsuka, Y Kakudo, S Takahashi and C Ishioka
Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer
advance online publication, 2009-11-17 00:00:00.000;
doi:10.1038/sj.bjc.6605432
Kakugawa, Y
H Shoda, Y Kakugawa, D Saito, T Kozu, T Terauchi, H Daisaki, C Hamashima, Y Muramatsu, N Moriyama and H Saito
Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy
advance online publication, 2007-11-27 00:00:00.000;
doi:10.1038/sj.bjc.6604062
Abstract | Full article | PDF
Kakuguchi, W
H Hasegawa, W Kakuguchi, T Kuroshima, T Kitamura, S Tanaka, Y Kitagawa, Y Totsuka, M Shindoh and F Higashino
HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
doi:10.1038/sj.bjc.6605084
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- 142|
- 143|
- 144|
- 145|
- 146|
- 147|
- 148|
- 149|
- 150|
- 151|
- 152|
- 153|
- 154|
- 155|
- 156|
- 157|
- 158|
- 159|
- 160|
- 161|
- 162|
- 163|
- 164|
- 165|
- 166|
- 167|
- 168|
- 169|
- 170|
- 171|
- 172|
- 173|
- 174|
- 175|
- 176|
- 177|
- 178|
- 179|
- 180|
- 181|
- 182|
- Next
